Absci Reports Business Updates and Third Quarter 2024 Financial …
2 days ago · Research and development expenses were $18.0 million for the three months ended September 30, 2024 compared to $11.0 million for the three months ended September 30, 2023.
Absci Reports Business Updates and Third Quarter 2024 Financial …
2 days ago · Cash, cash equivalents, and short-term investments as of September 30, 2024 were $127.1 million, compared to $145.2 million as of June 30, 2024. Absci will host a conference call to discuss its third quarter 2024 business updates and financial and operating results on Tuesday, November 12, 2024 at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific Time.
Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic ...
1 day ago · GuruFocus News. Wed, Nov 13, 2024, 2:07 AM3 min read. In This Article: ABSI. Revenue:$1.7 million for Q3 2024. Research and Development Expenses:$18 million for Q3 2024, up from $11 million in the ...
Absci Corporation Advances AI-Driven Drug Development
1 day ago · Nov. 12, 2024, 10:48 PM. Absci Corp. ( (ABSI) ) has released its Q3 earnings. Here is a breakdown of the information Absci Corp. presented to its investors. Absci Corporation, a data-first ...
Vancouver-based Absci marks major milestone in partnership with ...
1 day ago · The company reported Tuesday it brought in $1.7 million in its third quarter of 2024, up from $700,000 in the third quarter of 2023. It also reported a $27.4 million net loss, 24 cents per diluted ...
Q3 2024 Absci Corp Earnings Call - Yahoo Finance
2 days ago · Earlier today, Absci released financial and operating results for the quarter ended September 30 2024. If you haven't received this news release or if you would like to be added to the company's ...
News releases - Absci Corp
VANCOUVER, Wash. and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.
Investor Relations | Absci Corp
VANCOUVER, Wash. and NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the third quarter before market open on Tuesday,
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Absci Corporation (ABSI) stock quote, history, news and other vital information to help you with your stock trading and investing.
News Release Details - Absci Corp
Mar 21, 2024 · VANCOUVER, Wash. and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the fourth quarter and year ended December 31, 2023.
- Some results have been removed